Overview
- 24 inspections across 23 sites are on record.
- 20 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2014-04-29.
At a glance
Inspections
24
Sites
23
Observations
20
Career since
Jan 2008
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Zhejiang Raybow Pharmaceutical Co.,Ltd. | 29 Apr 2014 | Human Drugs | On file |
| China National Analytical Center | 1 Apr 2014 | Human Drugs | On file |
| China Resources Sanjiu Medical & Pharmaceutical CO., LTD. | 28 Mar 2014 | Human Drugs | On file |
| Yibin Lihao Bio-technical Co., Ltd. | 5 Mar 2014 | Human Drugs | On file |
| Beijing Yandu Limin Slaughter House Co., Ltd. | 21 Feb 2014 | Human Drugs | On file |
Sites inspected
Zhejiang Raybow Pharmaceutical Co.,Ltd.Taizhou, China1 insp.
China National Analytical CenterGuangzhou City, China1 insp.
China Resources Sanjiu Medical & Pharmaceutical CO., LTD.Shenzhen , China1 insp.
Yibin Lihao Bio-technical Co., Ltd.Yibin, China1 insp.
Beijing Yandu Limin Slaughter House Co., Ltd.Liulihe Town, Fangshan District, China1 insp.
Co-investigators
Investigators who share inspections with this person.
Gang Wang3 shared
Zi-Qiang Gu3 shared
Henry K Lau2 shared
Susan W Ting2 shared
Jeffrey D Meng1 shared
Kim L Thomas Cruse1 shared
Lance M De Souza1 shared
Peter E Baker1 shared
Brenda W Uratani1 shared
Full investigator report
Get the verbatim findings behind Carl Lee's 20 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site